Federal Agency for Medicines and Health Products
 | This article needs additional citations for verification. (August 2022) |
| Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG in Dutch) Agence fédérale des médicaments et des produits de santé (AFMPS in French) | |
| Agency overview | |
|---|---|
| Formed | January 1, 2007 |
| Preceding agency |
|
| Jurisdiction |  Belgium |
| Headquarters | Saint-Gilles, Brussels 50°50′10″N 4°20′00″E / 50.83611°N 4.33333°E |
| Employees | 458 (anno 2016) |
| Annual budget | Ca. 70,000,000 EUR |
| Minister responsible | |
| Agency executive |
|
| Parent department | Federal Public Service Health |
| Website | www |
The Federal Agency for Medicines and Health Products (FAMHP) of Belgium is responsible for the approval and registration of new medication in Belgium and for pharmacovigilance. Hugues Malonne is the current CEO of the agency.
The Dutch name is Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG) and in French it is called Agence Fédérale des Médicaments et des Produits de Santé (AFMPS).
The agency succeeded the Directoraat-generaal Geneesmiddelen / Direction Générale des Médicaments of the Federal Public Service Health as the new Competent Authority on 1 January 2007.
See also
[edit]- European Medicines Agency (Europe)
- Food and Drug Administration (USA)
